BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SSX1, MGC5162, 6756, ENSG00000126752, RP11-552E4_1, SSRC, MGC150425, Q16384 AND Diagnosis
11254 results:

  • 1. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in Cancer: A Systematic Review and Meta-Analysis.
    Gao L; Fan J; He J; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Drug Analysis of Voriconazole Combined with Granulocyte Colony Stimulating Factor.
    Zhang X; Li R; Wang H; Li H; Wu Y
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747920
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Characteristics and diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
    Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Triple Trouble.
    Diwan A; Barsode S
    J Assoc Physicians India; 2024 Mar; 72(3):97-99. PubMed ID: 38736127
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
    Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
    [No Abstract]    [Full Text] [Related]  

  • 7. Impact of body mass index at diagnosis on outcomes of pediatric acute leukemia: A systematic review and meta-analysis.
    Dong L; Dai G; Zhao J
    PLoS One; 2024; 19(5):e0302879. PubMed ID: 38709714
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Obesity and risk of relapse in patients with Acute Lymphoblastic leukemia: A retrospective study].
    Ramos-Peñafiel CO; Bejarano-Rosales MP; Gallardo-Rodríguez AG; Pérez-Sámano D; Leyton-Rivera HR; Olarte-Carrillo I; Martínez-Tovar A; Tarlovsky VF; Barranco-Lampón G; Alvarez-Altamirano K
    Rev Med Chil; 2023 May; 151(5):600-609. PubMed ID: 38687542
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hopelessness and Social Support among Cancer Patients in Saudi Arabia.
    Rawas H; De Beer J; Alturki O; Altorki M; Alhelali T; Althagfi A; Faisal N; Albalawi F; Khan MA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1363-1370. PubMed ID: 38679998
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
    Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
    Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. True Donor Cell leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
    Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
    Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
    Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge.
    Hsiao YS; Shen SC; Hsiao SC
    Am J Case Rep; 2024 Apr; 25():e943275. PubMed ID: 38644602
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transformation of Severe Aplastic Anemia into Donor Cell leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report.
    Wang Q; Xu H; Yu W; Sun L; Zhao H; Shi X
    Am J Case Rep; 2024 Apr; 25():e943801. PubMed ID: 38632857
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
    Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
    Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
    Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
    Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mental Health Care Utilization Among Parents of Children With Cancer.
    Hu X; Grosse SD; Han X; Marchak JG; Ji X
    JAMA Netw Open; 2024 Apr; 7(4):e244531. PubMed ID: 38564218
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predicting Stage Progression in Binet Stage a Chronic Lymphocytic leukemia.
    Alshemmari SH; Almazyad M; Alsarraf A; Kunhikrishnan A; Isaac AM; Kaempf A
    Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):137-145. PubMed ID: 38560969
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial.
    Bazinet A; Kantarjian H; Bataller A; Pemmaraju N; Borthakur G; Chien K; Alvarado Y; Bose P; Jabbour E; Yilmaz M; DiNardo C; Issa G; Montalban-Bravo G; Short N; Sasaki K; Bull-Linderman D; Daver N; Garcia-Manero G; Ravandi F; Kadia T
    Lancet Haematol; 2024 Apr; 11(4):e287-e298. PubMed ID: 38548404
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 563.